BSc (U of Birmingham, Fudan U), PhD (U of Cambridge)
Assistant Professor
L1-59, Laboratory Block, 21 Sassoon Road, Hong Kong
T +852 3917 6809
F +852 2817 0857
shikang@hku.hk
Dr Shikang Liang is currently an Assistant Professor in the School of Biomedical Science at the University of Hong Kong. He earned his BSc degree in Biotechnology from Fudan University. During his undergraduate, he joined the joint-undergraduate programme and earned BSc degree in Biochemistry with Honours Class I from University of Birmingham. He was also awarded a one-year exchange scholarship at University of California, Berkeley.
Dr Liang later earned his PhD degree in Biochemistry from the University of Cambridge and decided to continue his postdoctoral training at Cambridge. Since he started his PhD research in the lab of Professor Sir Tom Blundell in 2015, he has been focusing on structural and molecular investigation targeting human DNA damage response and repair. In 2023, he joined the University of Hong Kong as an Assistant Professor.
DNA is the main carrier of human genetic information. It must be delivered undamaged to the next generation to sustain inheritance and health. However, DNA damage is inevitable due to various exogenous and endogenous factors. A single human cell experiences tens of thousands of DNA lesions every day.
To avoid genome instability, relevant DNA damage response and repair (DDR&R) pathways cooperates in a timely and accurate manner. DDR&R is fundamental in genome stability and has exhibited high relevance to different diseases including cancer, immunodeficiency, and neurodegeneration. Drug discovery targeting human DDR&R has also been proved successful and promising in cancer treatment.
The Liang lab is interested in understanding the assembly and regulation of key multicomponent macromolecular complexes regulating DDR&R (e.g., DNA-dependent protein kinase and complexes), using state-of-the-art integrative biochemical, biophysical, and structural methods including cryo-electron microscopy (cryo-EM), and exploring how better molecular understanding of these complexes can assist future rational drug discovery.
* co-corresponding authors
Last Update : 2025-12-10